GlassScriptPhysician profile
Kathryn Casull
NPI 1831256635
$4,395.62
in general payments reported to CMS, 2019-2025
40 companies · $720 in 2025
The $720 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,483 · 2020: $279 · 2021: $19.16 · 2022: $419 · 2023: $809 · 2024: $667 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,196.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $538.99 | 2019-2024 | Evenity, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $489.99 | 2019-2025 | Jardiance, Spiriva Respimat, Synjardy |
| Pfizer INC. | $369.35 | 2019-2025 | |
| Glaxosmithkline, LLC. | $263.35 | 2019-2025 | Shingrix, Arexvy |
| Lilly USA, LLC | $252.91 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $245.79 | 2019-2024 | Veozah, Myrbetriq, Cresemba |
| Novo Nordisk INC | $222.12 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $213.74 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $189.85 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $175.55 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $152.14 | 2019-2020 | |
| Abbott Laboratories | $110.59 | 2019-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $105.53 | 2023-2025 | Dexcom G6 Transmitter |
| E.R. Squibb & Sons, L.L.C. | $100.71 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $98.64 | 2022-2023 | Quviviq |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Casull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.